Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermuscular coherence as a candidate biomarker for primary lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Predictions of Oncotype DX<sup>®</sup> High-Risk Classification Using Magnetic Resonance Imaging-Based Intratumoral Heterogeneity.

Bioengineering (Basel, Switzerland)·2026
Same author

Clinical safety and breast symmetry after injectable acellular dermal fibers reconstruction: an MR-based volumetric study.

Gland surgery·2026
Same author

Molecular insights into CRIP1 as an immunometabolic regulator revealed by CRIP1 knockout and single-cell transcriptomics.

Frontiers in immunology·2026
Same author

Clinical Reasoning: A 41-Year-Old Man Presenting With Right Foot Tingling.

Neurology·2026
Same author

Identification of Common Genes Regulated by ER Stress During the Development of Diabetic Nephropathy Based on Human Transcriptome Datasets and an In Vivo Mouse Model.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jul 11, 2026

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

FTY720 modulates human oligodendrocyte progenitor process extension and survival.

Veronique E Miron1, Cha Gyun Jung, Hye Jung Kim

  • 1Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Annals of Neurology
|October 6, 2007
PubMed
Summary

FTY720, a sphingosine-1-phosphate (S1P) receptor agonist, impacts human oligodendrocyte progenitor cells (OPCs). It initially retracts processes but later promotes extension and survival, crucial for multiple sclerosis remyelination.

More Related Videos

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

Related Experiment Videos

Last Updated: Jul 11, 2026

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Sphingosine-1-phosphate (S1P) receptor agonists, like FTY720, are investigated for multiple sclerosis immunotherapy.
  • Understanding FTY720's effects on oligodendrocyte progenitor cells (OPCs) is key for assessing remyelination potential.

Purpose of the Study:

  • To evaluate FTY720's impact on human OPC process extension, differentiation, and survival.
  • To correlate functional effects with S1P receptor expression and signaling pathways.

Main Methods:

  • Human fetal OPCs (A2B5+) were treated with phosphorylated FTY720.
  • Functional assays and quantitative real-time PCR assessed cell responses and receptor mRNA levels.
  • S1P receptor/signaling modulators were used to dissect FTY720's mechanism of action.

Main Results:

  • Short-term FTY720 treatment induced process retraction via RhoA signaling, inhibiting differentiation.
  • Prolonged FTY720 exposure promoted process extension and survival, linked to ERK1/2 phosphorylation and S1P1 agonism.
  • FTY720 modulated S1P1 and S1P5 receptor mRNA levels, suggesting sequential signaling through S1P5 then S1P1.

Conclusions:

  • FTY720 exerts time-dependent effects on human OPCs by modulating S1P receptors.
  • These modulations influence OPC function, including process extension and survival, relevant to remyelination in multiple sclerosis.